Samin Mohsenian: Can Factor VII Activity Predict Bleeding Severity?
Samin Mohsenian, Researcher at Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Advances, adding:
“I’m pleased to share our recent study on FVIID, analyzing 422 patients from three international registries.
FVII:C moderately stratifies bleeding severity, with levels less than 11 IU/dL associated with grade III bleeding, while equal to or more than 19 IU/dL helped identify asymptomatic individuals.”
Title: Genetic and Laboratory Predictors of Bleeding Severity in FVII Deficiency: Insights from PRO-RBDD and EN-RBD Databases
Authors: Samin Mohsenian, Andrea Cairo, Roberta Palla, Marzia Menegatti, Muriel Giansily-Blaizot, Mehran Karimi, Susan Halimeh, Munira Borhany, Helen Pergantou, Isabella Garagiola, Flora Peyvandi
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery